SEOM clinical guideline in ovarian cancer (2020)

被引：0

作者：

A. Redondo

E. Guerra

L. Manso

C. Martin-Lorente

J. Martinez-Garcia

J. A. Perez-Fidalgo

M. Q. Varela

M. J. Rubio

M. P. Barretina-Ginesta

A. Gonzalez-Martin

机构：

[1] Hospital Universitario La Paz-IdiPAZ,Girona Biomedical Research Institute (IdIBGi) and Department of Medical Sciences

[2] Universidad Autónoma de Madrid (UAM),undefined

[3] Hospital Universitario Ramón y Cajal,undefined

[4] Hospital Universitario 12 de Octubre-i+12,undefined

[5] Hospital de la Santa Creu i Sant Pau,undefined

[6] Hospital Clínico Universitario Virgen de la Arrixaca,undefined

[7] Hospital Clínico Universitario,undefined

[8] Biomedical Research Institute INCLIVA,undefined

[9] University of Valencia,undefined

[10] Complexo Hospitalario Universitario de A Coruña,undefined

[11] Hospital Universitario Reina Sofía,undefined

[12] Universidad de Córdoba (UCO),undefined

[13] Instituto Catalán de Oncología (ICO),undefined

[14] Medical School University of Girona,undefined

[15] Clínica Universidad de Navarra,undefined

来源：

Clinical and Translational Oncology | 2021年 / 23卷

关键词：

Ovarian cancer; Guideline; Diagnosis; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment. However, there is no doubt that the incorporation of PARP inhibitors as maintenance after the response to platinum-based chemotherapy, first in recurrent disease and recently also in first line, will change the natural history of the disease.

引用

页码：961 / 968

页数：7

共 50 条

[1] SEOM clinical guideline in ovarian cancer (2020)
Redondo, A.
Guerra, E.
Manso, L.
Martin-Lorente, C.
Martinez-Garcia, J.
Perez-Fidalgo, J. A.
Varela, M. Q.
Rubio, M. J.
Barretina-Ginesta, M. P.
Gonzalez-Martin, A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05) : 961 - 968
[2] SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)
Perez-Fidalgo, Jose Alejandro
Galvez-Montosa, Fernando
Guerra, Eva Maria
Madariaga, Ainhoa
Manzano, Aranzazu
Martin-Lorente, Cristina
Rubio-Perez, Maria Jesus
Alarcon, Jesus
Barretina-Ginesta, Maria Pilar
Gaba, Lydia
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2758 - 2770
[3] SEOM Clinical Guideline in ovarian cancer (2016)
Santaballa, A.
Barretina, P.
Casado, A.
Garcia, Y.
Gonzalez-Martin, A.
Guerra, E.
Lainez, N.
Martinez, J.
Redondo, A.
Romero, I.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12) : 1206 - 1212
[4] SEOM Clinical Guideline in ovarian cancer (2016)
A. Santaballa
P. Barretina
A. Casado
Y. García
A. González-Martín
E. Guerra
N. Laínez
J. Martinez
A. Redondo
I. Romero
Clinical and Translational Oncology, 2016, 18 : 1206 - 1212
[5] SEOM guideline in ovarian cancer 2014
A. Gonzalez-Martín
I. Bover
J. M. Del Campo
A. Redondo
L. Vidal
Clinical and Translational Oncology, 2014, 16 : 1067 - 1071
[6] SEOM guideline in ovarian cancer 2014
Gonzalez-Martin, A.
Bover, I.
Del Campo, J. M.
Redondo, A.
Vidal, L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12) : 1067 - 1071
[7] SEOM clinical guideline for management of adult medulloblastoma (2020)
Luque, R.
Benavides, M.
del Barco, S.
Egana, L.
Garcia-Gomez, J.
Martinez-Garcia, M.
Perez-Segura, P.
Pineda, E.
Sepulveda, J. M.
Vieito, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (05) : 940 - 947
[8] SEOM clinical guideline for management of adult medulloblastoma (2020)
R. Luque
M. Benavides
S. del Barco
L. Egaña
J. García-Gómez
M. Martínez-García
P. Pérez-Segura
E. Pineda
J. M. Sepúlveda
M. Vieito
Clinical and Translational Oncology, 2021, 23 : 940 - 947
[9] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Rueda Dominguez, Antonio
Cirauqui, Beatriz
Garcia Castano, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernandez, Beatriz
Iglesias Rey, Leticia
Rubio-Casadevall, Jordi
Arrazubi, Virginia
Mesia, Ricard
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 670 - 680
[10] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Antonio Rueda Domínguez
Beatriz Cirauqui
Almudena García Castaño
Ruth Alvarez Cabellos
Alberto Carral Maseda
Beatriz Castelo Fernández
Leticia Iglesias Rey
Jordi Rubió-Casadevall
Virginia Arrazubi
Ricard Mesía
Clinical and Translational Oncology, 2022, 24 : 670 - 680

← 1 2 3 4 5 →